Cargando…
Increased FGF21 plasma levels in humans with sepsis and SIRS
Fibroblast growth factor 21 (FGF21) is a key regulator in glucose and lipid metabolism and its plasma levels have been shown to be increased not only in humans in different situations such as type 2 diabetes, obesity, and nonalcoholic fatty liver disease but also in animal models of sepsis and pancr...
Autores principales: | Gariani, Karim, Drifte, Geneviève, Dunn-Siegrist, Irène, Pugin, Jérôme, Jornayvaz, François R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845842/ https://www.ncbi.nlm.nih.gov/pubmed/23999826 http://dx.doi.org/10.1530/EC-13-0040 |
Ejemplares similares
-
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report
por: Jornayvaz, François R., et al.
Publicado: (2020) -
Innate Immune Deficiency of Extremely Premature Neonates Can Be Reversed by Interferon-γ
por: Tissières, Pierre, et al.
Publicado: (2012) -
Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021) -
NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022) -
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
por: Nascè, Alberto, et al.
Publicado: (2022)